US Stock MarketDetailed Quotes

SNY Sanofi

Watchlist
  • 48.800
  • +0.520+1.08%
Trading Nov 27 15:42 ET
122.35BMarket Cap25.92P/E (TTM)

Sanofi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
(FY)Dec 31, 2016
(FY)Dec 31, 2015
(FY)Dec 31, 2014
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2.55%10.26B
0.04%10.53B
41.84%10.52B
-3.85%7.42B
39.08%7.72B
-24.83%5.55B
-5.86%7.38B
-5.45%7.84B
15.70%8.29B
9.26%7.17B
Net income from continuing operations
-35.49%5.4B
34.52%8.37B
-49.38%6.22B
346.41%12.29B
-36.04%2.75B
-48.84%4.31B
78.72%8.42B
9.84%4.71B
-2.35%4.29B
18.14%4.39B
Operating gains losses
113.42%69M
-623.94%-514M
99.02%-71M
-3,106.19%-7.25B
77.03%-226M
-926.89%-984M
235.23%119M
-151.16%-88M
102.35%172M
198.84%85M
Depreciation and amortization
40.12%4.79B
2.06%3.42B
-8.72%3.35B
-50.69%3.67B
73.99%7.45B
16.09%4.28B
11.66%3.69B
-22.80%3.3B
30.37%4.28B
-35.62%3.28B
Deferred tax
-67.82%-970M
-62.36%-578M
-61.09%-356M
87.53%-221M
-143.74%-1.77B
20.02%-727M
-67.71%-909M
56.74%-542M
-8.86%-1.25B
-27.75%-1.15B
Other non cash items
33.46%339M
8,366.67%254M
100.48%3M
-257.47%-622M
-179.82%-174M
104.95%218M
-1,022.70%-4.4B
-67.52%-392M
-966.67%-234M
121.09%27M
Change In working capital
208.06%764M
-150.18%-707M
533.54%1.41B
22.43%-325M
67.27%-419M
-970.75%-1.28B
-82.29%147M
-21.33%830M
16.19%1.06B
365.64%908M
-Change in receivables
48.91%-397M
-520.00%-777M
238.06%185M
71.00%-134M
-1,220.00%-462M
93.38%-35M
-414.88%-529M
134.08%168M
-2,365.00%-493M
-115.04%-20M
-Change in inventory
9.39%-840M
-159.66%-927M
39.80%-357M
-8.41%-593M
21.97%-547M
-386.81%-701M
55.83%-144M
30.04%-326M
-5,725.00%-466M
83.33%-8M
-Change in payables and accrued expense
-11.06%402M
0.22%452M
424.42%451M
-49.11%86M
-37.41%169M
-53.21%270M
29.08%577M
85.48%447M
-47.49%241M
470.16%459M
-Change in other working capital
193.39%1.6B
-51.77%545M
257.59%1.13B
-24.94%316M
151.72%421M
-434.98%-814M
-55.08%243M
-69.49%541M
271.70%1.77B
103.85%477M
Cash from discontinued investing activities
-45.08%346M
20.00%630M
32.58%525M
Operating cash flow
-2.55%10.26B
0.04%10.53B
41.84%10.52B
-3.85%7.42B
39.08%7.72B
-24.83%5.55B
-9.84%7.38B
-8.25%8.18B
15.99%8.92B
10.58%7.69B
Investing cash flow
Cash flow from continuing investing activities
-198.80%-6.2B
71.57%-2.08B
-301.66%-7.3B
405.92%3.62B
90.81%-1.18B
-344.27%-12.87B
-15.33%-2.9B
16.61%-2.51B
10.31%-3.01B
-184.97%-3.36B
Net PPE purchase and sale
-181.77%-2.01B
47.84%-713M
-17.34%-1.37B
-106.93%-1.17B
-402.69%-563M
113.09%186M
24.17%-1.42B
26.83%-1.87B
-115.03%-2.56B
-32.63%-1.19B
Net business purchase and sale
-346.15%-3.83B
84.55%-858M
-210.29%-5.55B
1,131.56%5.03B
96.20%-488M
-1,017.03%-12.86B
-170.19%-1.15B
-93.64%-426M
87.23%-220M
-633.19%-1.72B
Net investment purchase and sale
72.54%-134M
-56.91%-488M
-127.01%-311M
-260.53%-137M
72.26%-38M
-124.59%-137M
43.52%-61M
23.94%-108M
75.13%-142M
-3,072.22%-571M
Net other investing changes
-1,331.25%-229M
76.47%-16M
39.82%-68M
-20.21%-113M
-62.07%-94M
77.95%-58M
-155.34%-263M
-17.05%-103M
-168.75%-88M
574.07%128M
Cash from discontinued investing activities
Investing cash flow
-198.80%-6.2B
71.57%-2.08B
-301.66%-7.3B
451.70%3.62B
92.01%-1.03B
-2,114.40%-12.87B
124.23%639M
19.04%-2.64B
5.87%-3.26B
-171.80%-3.46B
Financing cash flow
Cash flow from continuing financing activities
-38.33%-8.05B
17.50%-5.82B
-8.80%-7.06B
-54.66%-6.49B
-206.58%-4.19B
149.78%3.93B
-92.68%-7.9B
-14.62%-4.1B
31.11%-3.58B
-38.25%-5.19B
Net issuance payments of debt
-151.89%-3.14B
55.60%-1.25B
-48.75%-2.8B
-283.91%-1.89B
-105.63%-491M
479.71%8.72B
-200.17%-2.3B
70.36%2.29B
445.13%1.35B
-168.66%-390M
Net common stock issuance
-28.80%-398M
-57.65%-309M
68.34%-196M
-504.58%-619M
116.56%153M
49.86%-924M
29.20%-1.84B
-115.12%-2.6B
-8.04%-1.21B
-76.38%-1.12B
Cash dividends paid
-6.86%-4.45B
-3.99%-4.17B
-1.80%-4.01B
-2.69%-3.94B
-1.62%-3.83B
-1.70%-3.77B
1.30%-3.71B
-1.76%-3.76B
-0.49%-3.69B
-1.04%-3.68B
Net other financing activities
35.35%-64M
-106.25%-99M
-9.09%-48M
-109.52%-44M
76.92%-21M
-75.00%-91M
-62.50%-52M
-60.00%-32M
-150.00%-20M
84.62%-8M
Cash from discontinued financing activities
582.61%111M
-264.29%-23M
-54.84%14M
Financing cash flow
-38.33%-8.05B
17.50%-5.82B
-8.80%-7.06B
-54.66%-6.49B
-206.58%-4.19B
149.78%3.93B
-98.05%-7.9B
-10.80%-3.99B
30.48%-3.6B
-39.02%-5.18B
Net cash flow
Beginning cash position
26.12%12.74B
-27.43%10.1B
47.61%13.92B
36.13%9.43B
-32.86%6.93B
0.41%10.32B
12.30%10.27B
24.62%9.15B
-11.09%7.34B
29.40%8.26B
Current changes in cash
-251.86%-3.99B
168.63%2.63B
-184.18%-3.83B
82.59%4.55B
173.52%2.49B
-3,023.28%-3.39B
-92.55%116M
-23.64%1.56B
314.63%2.04B
-148.59%-950M
Effect of exchange rate changes
-500.00%-32M
-46.67%8M
123.44%15M
-811.11%-64M
800.00%9M
101.35%1M
26.73%-74M
56.47%-101M
-782.35%-232M
143.04%34M
End cash Position
-31.61%8.71B
26.12%12.74B
-27.43%10.1B
47.61%13.92B
36.13%9.43B
-32.86%6.93B
-2.73%10.32B
15.92%10.6B
24.62%9.15B
-11.09%7.34B
Free cash flow
-13.11%7.23B
-1.82%8.33B
58.93%8.48B
-10.00%5.34B
66.05%5.93B
-34.17%3.57B
-11.11%5.42B
-0.76%6.1B
-1.43%6.15B
10.43%6.24B
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017(FY)Dec 31, 2016(FY)Dec 31, 2015(FY)Dec 31, 2014
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2.55%10.26B0.04%10.53B41.84%10.52B-3.85%7.42B39.08%7.72B-24.83%5.55B-5.86%7.38B-5.45%7.84B15.70%8.29B9.26%7.17B
Net income from continuing operations -35.49%5.4B34.52%8.37B-49.38%6.22B346.41%12.29B-36.04%2.75B-48.84%4.31B78.72%8.42B9.84%4.71B-2.35%4.29B18.14%4.39B
Operating gains losses 113.42%69M-623.94%-514M99.02%-71M-3,106.19%-7.25B77.03%-226M-926.89%-984M235.23%119M-151.16%-88M102.35%172M198.84%85M
Depreciation and amortization 40.12%4.79B2.06%3.42B-8.72%3.35B-50.69%3.67B73.99%7.45B16.09%4.28B11.66%3.69B-22.80%3.3B30.37%4.28B-35.62%3.28B
Deferred tax -67.82%-970M-62.36%-578M-61.09%-356M87.53%-221M-143.74%-1.77B20.02%-727M-67.71%-909M56.74%-542M-8.86%-1.25B-27.75%-1.15B
Other non cash items 33.46%339M8,366.67%254M100.48%3M-257.47%-622M-179.82%-174M104.95%218M-1,022.70%-4.4B-67.52%-392M-966.67%-234M121.09%27M
Change In working capital 208.06%764M-150.18%-707M533.54%1.41B22.43%-325M67.27%-419M-970.75%-1.28B-82.29%147M-21.33%830M16.19%1.06B365.64%908M
-Change in receivables 48.91%-397M-520.00%-777M238.06%185M71.00%-134M-1,220.00%-462M93.38%-35M-414.88%-529M134.08%168M-2,365.00%-493M-115.04%-20M
-Change in inventory 9.39%-840M-159.66%-927M39.80%-357M-8.41%-593M21.97%-547M-386.81%-701M55.83%-144M30.04%-326M-5,725.00%-466M83.33%-8M
-Change in payables and accrued expense -11.06%402M0.22%452M424.42%451M-49.11%86M-37.41%169M-53.21%270M29.08%577M85.48%447M-47.49%241M470.16%459M
-Change in other working capital 193.39%1.6B-51.77%545M257.59%1.13B-24.94%316M151.72%421M-434.98%-814M-55.08%243M-69.49%541M271.70%1.77B103.85%477M
Cash from discontinued investing activities -45.08%346M20.00%630M32.58%525M
Operating cash flow -2.55%10.26B0.04%10.53B41.84%10.52B-3.85%7.42B39.08%7.72B-24.83%5.55B-9.84%7.38B-8.25%8.18B15.99%8.92B10.58%7.69B
Investing cash flow
Cash flow from continuing investing activities -198.80%-6.2B71.57%-2.08B-301.66%-7.3B405.92%3.62B90.81%-1.18B-344.27%-12.87B-15.33%-2.9B16.61%-2.51B10.31%-3.01B-184.97%-3.36B
Net PPE purchase and sale -181.77%-2.01B47.84%-713M-17.34%-1.37B-106.93%-1.17B-402.69%-563M113.09%186M24.17%-1.42B26.83%-1.87B-115.03%-2.56B-32.63%-1.19B
Net business purchase and sale -346.15%-3.83B84.55%-858M-210.29%-5.55B1,131.56%5.03B96.20%-488M-1,017.03%-12.86B-170.19%-1.15B-93.64%-426M87.23%-220M-633.19%-1.72B
Net investment purchase and sale 72.54%-134M-56.91%-488M-127.01%-311M-260.53%-137M72.26%-38M-124.59%-137M43.52%-61M23.94%-108M75.13%-142M-3,072.22%-571M
Net other investing changes -1,331.25%-229M76.47%-16M39.82%-68M-20.21%-113M-62.07%-94M77.95%-58M-155.34%-263M-17.05%-103M-168.75%-88M574.07%128M
Cash from discontinued investing activities
Investing cash flow -198.80%-6.2B71.57%-2.08B-301.66%-7.3B451.70%3.62B92.01%-1.03B-2,114.40%-12.87B124.23%639M19.04%-2.64B5.87%-3.26B-171.80%-3.46B
Financing cash flow
Cash flow from continuing financing activities -38.33%-8.05B17.50%-5.82B-8.80%-7.06B-54.66%-6.49B-206.58%-4.19B149.78%3.93B-92.68%-7.9B-14.62%-4.1B31.11%-3.58B-38.25%-5.19B
Net issuance payments of debt -151.89%-3.14B55.60%-1.25B-48.75%-2.8B-283.91%-1.89B-105.63%-491M479.71%8.72B-200.17%-2.3B70.36%2.29B445.13%1.35B-168.66%-390M
Net common stock issuance -28.80%-398M-57.65%-309M68.34%-196M-504.58%-619M116.56%153M49.86%-924M29.20%-1.84B-115.12%-2.6B-8.04%-1.21B-76.38%-1.12B
Cash dividends paid -6.86%-4.45B-3.99%-4.17B-1.80%-4.01B-2.69%-3.94B-1.62%-3.83B-1.70%-3.77B1.30%-3.71B-1.76%-3.76B-0.49%-3.69B-1.04%-3.68B
Net other financing activities 35.35%-64M-106.25%-99M-9.09%-48M-109.52%-44M76.92%-21M-75.00%-91M-62.50%-52M-60.00%-32M-150.00%-20M84.62%-8M
Cash from discontinued financing activities 582.61%111M-264.29%-23M-54.84%14M
Financing cash flow -38.33%-8.05B17.50%-5.82B-8.80%-7.06B-54.66%-6.49B-206.58%-4.19B149.78%3.93B-98.05%-7.9B-10.80%-3.99B30.48%-3.6B-39.02%-5.18B
Net cash flow
Beginning cash position 26.12%12.74B-27.43%10.1B47.61%13.92B36.13%9.43B-32.86%6.93B0.41%10.32B12.30%10.27B24.62%9.15B-11.09%7.34B29.40%8.26B
Current changes in cash -251.86%-3.99B168.63%2.63B-184.18%-3.83B82.59%4.55B173.52%2.49B-3,023.28%-3.39B-92.55%116M-23.64%1.56B314.63%2.04B-148.59%-950M
Effect of exchange rate changes -500.00%-32M-46.67%8M123.44%15M-811.11%-64M800.00%9M101.35%1M26.73%-74M56.47%-101M-782.35%-232M143.04%34M
End cash Position -31.61%8.71B26.12%12.74B-27.43%10.1B47.61%13.92B36.13%9.43B-32.86%6.93B-2.73%10.32B15.92%10.6B24.62%9.15B-11.09%7.34B
Free cash flow -13.11%7.23B-1.82%8.33B58.93%8.48B-10.00%5.34B66.05%5.93B-34.17%3.57B-11.11%5.42B-0.76%6.1B-1.43%6.15B10.43%6.24B
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion----Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.93%